Clinical Trial

IOP Reduction in Pigmentary Glaucoma Using DSLT

Recruiting
View on ClinicalTrials.gov →
Summary
This study is a single-site, single-arm, prospective, observational study of IOP reduction after DSLT. Subjects will be assessed up to 12 months post-operatively. Clinical evaluations will include IOP and number of glaucoma medications.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-01.
Status change: Not Yet Recruiting → Recruiting 2026-04-08
Trial Details
NCT Number NCT07281391
Lead Sponsor Mann Eye Institute
Collaborators: Sengi
Conditions Pigmentary Dispersion Syndrome, Pigmentary Dispersion Glaucoma
Enrollment 45 participants
Start Date 2026-03-19
Primary Completion 2027-04-01 (estimated)
Study Completion 2027-04-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-09